Metalyse 5'000 U, Pulver zur Herstellung einer Injektionslösung

7680699580019 CH-69958 Pulver

Associated product:

METALYSE 5'000 U subst seche 25 mg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/08/2025
Summary of Product Characteristics
Français
22/08/2025
Summary of Product Characteristics
Italien
22/08/2025

Detailed composition

Substance Quantity Type Category
tenecteplasum
25.0 MG Substance Wirkstoff (Principe actif)
argininum
- Substance HNIDK
acidum phosphoricum concentratum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
69958
Drug name
Metalyse, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
B01AD11
Authorization status
Z
Dispensing category
B
First authorization
18/08/2025
Authorization expiration date
17/08/2030
IT Number
06.05.0.
Domain
Human medicine
Field of application
Thrombolytische Therapie bei akutem ischämischem Schlaganfall

Package details

Description (FR)
METALYSE 5'000 U subst seche 25 mg 1 pce
Description (DE)
METALYSE 5'000 U Trockensub 25 mg 1 Stk
Market launch
01/10/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data